SCOPUS 정보 검색 플랫폼

Heart Rhythm

Volumn 2, Issue 5, 2005, Pages 544-549

Symptomatic burden as an endpoint to evaluate interventions in patients with atrial fibrillation

(2) Darbar, Dawood a Roden, Dan M a

a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

Atrial fibrillation; Burden; Endpoints; Therapies

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; PLACEBO; PROPAFENONE; SOTALOL; WARFARIN;

ACCURACY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CATHETER ABLATION; CONSENSUS DEVELOPMENT; CORRELATION ANALYSIS; DEATH; DISEASE DURATION; DISEASE SEVERITY; HEART ATRIUM FIBRILLATION; HUMAN; INTERVIEW; MEDICAL ASSESSMENT; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; STROKE; SYMPTOM; THROMBOEMBOLISM; TREATMENT OUTCOME; WELLBEING;

ALGORITHMS; ATRIAL FIBRILLATION; COST OF ILLNESS; HUMANS; MONITORING, PHYSIOLOGIC; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; RECURRENCE; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

EID: 17144363572 PISSN: 15475271 EISSN: None Source Type: Journal
DOI: 10.1016/j.hrthm.2005.01.028 Document Type: Article

Times cited : (24)

References (48)

1
- 0037028022
- A comparison of rate control and rhythm control in patients with atrial fibrillation
- D.G. Wyse A.L. Waldo J.P. DiMarco M.J. Domanski Y. Rosenberg E.B. Schron J.C. Kellen H.L. Greene M.C. Mickel J.E. Dalquist S.D. Corley A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825-1833
- (2002) N. Engl. J. Med. , vol.347 , pp. 1825-1833
- Wyse, D.G.¹ Waldo, A.L.² DiMarco, J.P.³ Domanski, M.J.⁴ Rosenberg, Y.⁵ Schron, E.B.⁶ Kellen, J.C.⁷ Greene, H.L.⁸ Mickel, M.C.⁹ Dalquist, J.E.¹⁰ Corley, S.D.¹¹

2
- 0034715973
- Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial
- S.H. Hohnloser K.H. Kuck J. Lilienthal Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial Lancet 356 2000 1789-1794
- (2000) Lancet , vol.356 , pp. 1789-1794
- Hohnloser, S.H.¹ Kuck, K.H.² Lilienthal, J.³

3
- 0037028033
- A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation
- I.C. Van Gelder V.E. Hagens H.A. Bosker J.H. Kingma O. Kamp T. Kingma S.A. Said J.I. Darmanata A.J. Timmermans J.G. Tijssen H.J. Crijns A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834-1840
- (2002) N. Engl. J. Med. , vol.347 , pp. 1834-1840
- Van Gelder, I.C.¹ Hagens, V.E.² Bosker, H.A.³ Kingma, J.H.⁴ Kamp, O.⁵ Kingma, T.⁶ Said, S.A.⁷ Darmanata, J.I.⁸ Timmermans, A.J.⁹ Tijssen, J.G.¹⁰ Crijns, H.J.¹¹

4
- 1842434297
- Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
- S.D. Corley A.E. Epstein J.P. DiMarco M.J. Domanski N. Geller H.L. Greene R.A. Josephson J.C. Kellen R.C. Klein A.D. Krahn M. Mickel L.B. Mitchell J.D. Nelson Y. Rosenberg E. Schron L. Shemanski A.L. Waldo D.G. Wyse Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study Circulation 109 2004 1509-1513
- (2004) Circulation , vol.109 , pp. 1509-1513
- Corley, S.D.¹ Epstein, A.E.² DiMarco, J.P.³ Domanski, M.J.⁴ Geller, N.⁵ Greene, H.L.⁶ Josephson, R.A.⁷ Kellen, J.C.⁸ Klein, R.C.⁹ Krahn, A.D.¹⁰ Mickel, M.¹¹ Mitchell, L.B.¹² Nelson, J.D.¹³ Rosenberg, Y.¹⁴ Schron, E.¹⁵ Shemanski, L.¹⁶ Waldo, A.L.¹⁷ Wyse, D.G.¹⁸

5
- 0038037760
- Familial atrial fibrillation is a genetically heterogeneous disorder
- D. Darbar K.J. Herron J.D. Ballew A. Jahangir B.J. Gersh W.K. Shen S.C. Hammill D.L. Packer T.M. Olson Familial atrial fibrillation is a genetically heterogeneous disorder J Am Coll Cardiol 41 2003 2185-2192
- (2003) J. Am. Coll. Cardiol. , vol.41 , pp. 2185-2192
- Darbar, D.¹ Herron, K.J.² Ballew, J.D.³ Jahangir, A.⁴ Gersh, B.J.⁵ Shen, W.K.⁶ Hammill, S.C.⁷ Packer, D.L.⁸ Olson, T.M.⁹

6
- 0037635439
- Locus for atrial fibrillation maps to chromosome 6q14-16
- P.T. Ellinor J.T. Shin R.K. Moore D.M. Yoerger C.A. MacRae Locus for atrial fibrillation maps to chromosome 6q14-16 Circulation 107 2003 2880-2883
- (2003) Circulation , vol.107 , pp. 2880-2883
- Ellinor, P.T.¹ Shin, J.T.² Moore, R.K.³ Yoerger, D.M.⁴ MacRae, C.A.⁵

7
- 0031004845
- Identification of a genetic locus for familial atrial fibrillation
- R. Brugada T. Tapscott G.Z. Czernuszewicz A.J. Marian A. Iglesias L. Mont J. Brugada J. Girona A. Domingo L.L. Bachinski R. Roberts Identification of a genetic locus for familial atrial fibrillation N Engl J Med 336 1997 905-911
- (1997) N. Engl. J. Med. , vol.336 , pp. 905-911
- Brugada, R.¹ Tapscott, T.² Czernuszewicz, G.Z.³ Marian, A.J.⁴ Iglesias, A.⁵ Mont, L.⁶ Brugada, J.⁷ Girona, J.⁸ Domingo, A.⁹ Bachinski, L.L.¹⁰ Roberts, R.¹¹

8
- 2942537772
- Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring
- C.S. Fox H. Parise R.B. D'Agostino Sr D.M. Lloyd-Jones R.S. Vasan T.J. Wang D. Levy P.A. Wolf E.J. Benjamin Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring JAMA 291 2004 2851-2855
- (2004) JAMA , vol.291 , pp. 2851-2855
- Fox, C.S.¹ Parise, H.² D'Agostino Sr., R.B.³ Lloyd-Jones, D.M.⁴ Vasan, R.S.⁵ Wang, T.J.⁶ Levy, D.⁷ Wolf, P.A.⁸ Benjamin, E.J.⁹

9
- 11144305032
- Genome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy
- C. Oberti L. Wang L. Li J. Dong S. Rao W. Du Q. Wang Genome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy Circulation 110 2004 3753-3759
- (2004) Circulation , vol.110 , pp. 3753-3759
- Oberti, C.¹ Wang, L.² Li, L.³ Dong, J.⁴ Rao, S.⁵ Du, W.⁶ Wang, Q.⁷

10
- 0346995016
- Inflammation as a risk factor for atrial fibrillation
- R.J. Aviles D.O. Martin C. Apperson-Hansen P.L. Houghtaling P. Rautaharju R.A. Kronmal R.P. Tracy D.R. Van Wagoner B.M. Psaty M.S. Lauer M.K. Chung Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006-3010
- (2003) Circulation , vol.108 , pp. 3006-3010
- Aviles, R.J.¹ Martin, D.O.² Apperson-Hansen, C.³ Houghtaling, P.L.⁴ Rautaharju, P.⁵ Kronmal, R.A.⁶ Tracy, R.P.⁷ Van Wagoner, D.R.⁸ Psaty, B.M.⁹ Lauer, M.S.¹⁰ Chung, M.K.¹¹

11
- 0037118662
- Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: A prospective and randomized study
- A.H. Madrid M.G. Bueno J.M. Rebollo I. Marin G. Pena E. Bernal A. Rodriguez L. Cano J.M. Cano P. Cabeza C. Moro Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: A prospective and randomized study Circulation 106 2002 331-336
- (2002) Circulation , vol.106 , pp. 331-336
- Madrid, A.H.¹ Bueno, M.G.² Rebollo, J.M.³ Marin, I.⁴ Pena, G.⁵ Bernal, E.⁶ Rodriguez, A.⁷ Cano, L.⁸ Cano, J.M.⁹ Cabeza, P.¹⁰ Moro, C.¹¹

12
- 0033609470
- Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction
- O.D. Pedersen H. Bagger L. Kober C. Torp-Pedersen Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction Circulation 100 1999 376-380
- (1999) Circulation , vol.100 , pp. 376-380
- Pedersen, O.D.¹ Bagger, H.² Kober, L.³ Torp-Pedersen, C.⁴

13
- 0038649984
- Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: Insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials
- E. Vermes J.C. Tardif M.G. Bourassa N. Racine S. Levesque M. White P.G. Guerra A. Ducharme Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: Insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials Circulation 107 2003 2926-2931
- (2003) Circulation , vol.107 , pp. 2926-2931
- Vermes, E.¹ Tardif, J.C.² Bourassa, M.G.³ Racine, N.⁴ Levesque, S.⁵ White, M.⁶ Guerra, P.G.⁷ Ducharme, A.⁸

14
- 11144355187
- Renin-angiotensin system gene polymorphisms and atrial fibrillation
- C.T. Tsai L.P. Lai J.L. Lin F.T. Chiang J.J. Hwang M.D. Ritchie J.H. Moore K.L. Hsu C.D. Tseng C.S. Liau Y.Z. Tseng Renin-angiotensin system gene polymorphisms and atrial fibrillation Circulation 109 2004 1640-1646
- (2004) Circulation , vol.109 , pp. 1640-1646
- Tsai, C.T.¹ Lai, L.P.² Lin, J.L.³ Chiang, F.T.⁴ Hwang, J.J.⁵ Ritchie, M.D.⁶ Moore, J.H.⁷ Hsu, K.L.⁸ Tseng, C.D.⁹ Liau, C.S.¹⁰ Tseng, Y.Z.¹¹

15
- 13844295308
- Catheter ablation for atrial fibrillation in congestive heart failure
- L.F. Hsu P. Jais P. Sanders S. Garrigue M. Hocini F. Sacher Y. Takahashi M. Rotter J.L. Pasquie C. Scavee P. Bordachar J. Clementy M. Haissaguerre Catheter ablation for atrial fibrillation in congestive heart failure N Engl J Med 351 2004 2373-2383
- (2004) N. Engl. J. Med. , vol.351 , pp. 2373-2383
- Hsu, L.F.¹ Jais, P.² Sanders, P.³ Garrigue, S.⁴ Hocini, M.⁵ Sacher, F.⁶ Takahashi, Y.⁷ Rotter, M.⁸ Pasquie, J.L.⁹ Scavee, C.¹⁰ Bordachar, P.¹¹ Clementy, J.¹² Haissaguerre, M.¹³

16
- 0036155046
- Selection of endpoints in atrial fibrillation studies
- D.G. Wyse Selection of endpoints in atrial fibrillation studies J Cardiovasc Electrophysiol 13 2002 S47-S52
- (2002) J. Cardiovasc. Electrophysiol. , vol.13
- Wyse, D.G.¹

17
- 0031686381
- Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction
- D.L. Dries D.V. Exner B.J. Gersh M.J. Domanski M.A. Waclawiw L.W. Stevenson Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction J Am Coll Cardiol 32 1998 695-703
- (1998) J. Am. Coll. Cardiol. , vol.32 , pp. 695-703
- Dries, D.L.¹ Exner, D.V.² Gersh, B.J.³ Domanski, M.J.⁴ Waclawiw, M.A.⁵ Stevenson, L.W.⁶

18
- 0034849614
- Atrial fibrillation: A risk factor for increased mortality-An AVID registry analysis
- D.G. Wyse J.C. Love Q. Yao M.D. Carlson P. Cassidy L.H. Greene J.B. Martins C. Ocampo M.H. Raitt E. Schron N.J. Stamato A. Olarte Atrial fibrillation: A risk factor for increased mortality-An AVID registry analysis J Interv Card Electrophysiol 5 2001 267-273
- (2001) J. Interv. Card. Electrophysiol. , vol.5 , pp. 267-273
- Wyse, D.G.¹ Love, J.C.² Yao, Q.³ Carlson, M.D.⁴ Cassidy, P.⁵ Greene, L.H.⁶ Martins, J.B.⁷ Ocampo, C.⁸ Raitt, M.H.⁹ Schron, E.¹⁰ Stamato, N.J.¹¹ Olarte, A.¹²

19
- 3042733004
- Mortality as an endpoint in atrial fibrillation
- D.M. Beyerbach D.P. Zipes Mortality as an endpoint in atrial fibrillation Heart Rhythm 1 2004 8-19
- (2004) Heart Rhythm , vol.1 , pp. 8-19
- Beyerbach, D.M.¹ Zipes, D.P.²

20
- 3042773839
- Overview of symposium: Outcomes in AF trials
- R. Mehra G.D. Wyse Overview of symposium: Outcomes in AF trials Heart Rhythm 1 2004 1-2
- (2004) Heart Rhythm , vol.1 , pp. 1-2
- Mehra, R.¹ Wyse, G.D.²

21
- 0033603814
- Are surrogate markers adequate to assess cardiovascular disease drugs?
- R. Temple Are surrogate markers adequate to assess cardiovascular disease drugs? JAMA 282 1999 790-795
- (1999) JAMA , vol.282 , pp. 790-795
- Temple, R.¹

22
- 0026011647
- Mortality and morbidity in patients receiving encainide, flecainide, or placebo
- The Cardiac Arrhythmia Suppression Trial
- D.S. Echt P.R. Liebson L.B. Mitchell R.W. Peters D. Obias-Manno A.H. Barker D. Arensberg A. Baker L. Friedman H.L. Greene Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial N Engl J Med 324 1991 781-788
- (1991) N. Engl. J. Med. , vol.324 , pp. 781-788
- Echt, D.S.¹ Liebson, P.R.² Mitchell, L.B.³ Peters, R.W.⁴ Obias-Manno, D.⁵ Barker, A.H.⁶ Arensberg, D.⁷ Baker, A.⁸ Friedman, L.⁹ Greene, H.L.¹⁰

23
- 17144421908
- Difference between symptom-free and recurrence-free survival after either circumferential or segmental pulmonary vein ablation of atrial fibrillation
- (abstr)
- M.R. Karch B. Zrenner I. Deisenhofer J. Schreieck C. Schmitt Difference between symptom-free and recurrence-free survival after either circumferential or segmental pulmonary vein ablation of atrial fibrillation (abstr) Circulation 110 2004 SIII-459
- (2004) Circulation , vol.110
- Karch, M.R.¹ Zrenner, B.² Deisenhofer, I.³ Schreieck, J.⁴ Schmitt, C.⁵

24
- 0021239340
- The spontaneous occurrence of paroxysmal supraventricular tachycardia
- E.L. Pritchett M.S. Smith E.A. McCarthy K.L. Lee The spontaneous occurrence of paroxysmal supraventricular tachycardia Circulation 70 1984 1-6
- (1984) Circulation , vol.70 , pp. 1-6
- Pritchett, E.L.¹ Smith, M.S.² McCarthy, E.A.³ Lee, K.L.⁴

25
- 0024374784
- Random and nonrandom behavior of symptomatic paroxysmal atrial fibrillation
- G.S. Greer W.E. Wilkinson E.A. McCarthy E.L. Pritchett Random and nonrandom behavior of symptomatic paroxysmal atrial fibrillation Am J Cardiol 64 1989 339-342
- (1989) Am. J. Cardiol. , vol.64 , pp. 339-342
- Greer, G.S.¹ Wilkinson, W.E.² McCarthy, E.A.³ Pritchett, E.L.⁴

26
- 0033616432
- Evaluation of the bias in using the time to the first event when the inter-event intervals have a Weibull distribution
- M.S. Rose A.M. Gillis R.S. Sheldon Evaluation of the bias in using the time to the first event when the inter-event intervals have a Weibull distribution Stat Med 18 1999 139-154
- (1999) Stat. Med. , vol.18 , pp. 139-154
- Rose, M.S.¹ Gillis, A.M.² Sheldon, R.S.³

27
- 0035109599
- Distribution of patients' paroxysmal atrial tachyarrhythmia episodes: Implications for detection of treatment efficacy
- W.F. Kaemmerer M.S. Rose R. Mehra Distribution of patients' paroxysmal atrial tachyarrhythmia episodes: Implications for detection of treatment efficacy J Cardiovasc Electrophysiol 12 2001 121-130
- (2001) J. Cardiovasc. Electrophysiol. , vol.12 , pp. 121-130
- Kaemmerer, W.F.¹ Rose, M.S.² Mehra, R.³

28
- 0036105526
- Temporal patterns of atrial arrhythmia recurrences in patients with implantable defibrillators: Implications for assessing antiarrhythmic therapies
- L.A. Shehadeh L.S. Liebovitch M.A. Wood Temporal patterns of atrial arrhythmia recurrences in patients with implantable defibrillators: implications for assessing antiarrhythmic therapies J Cardiovasc Electrophysiol 13 2002 303-309
- (2002) J. Cardiovasc. Electrophysiol. , vol.13 , pp. 303-309
- Shehadeh, L.A.¹ Liebovitch, L.S.² Wood, M.A.³

29
- 0034665058
- Ionic remodelling in the heart: Pathophysiological significance and new therapeutic opportunities for atrial fibrillation
- S. Nattel D. Li Ionic remodelling in the heart: Pathophysiological significance and new therapeutic opportunities for atrial fibrillation Circ Res 87 2000 440-447
- (2000) Circ. Res. , vol.87 , pp. 440-447
- Nattel, S.¹ Li, D.²

30
- 4644283878
- Clustering of RR intervals predicts effective electrical cardioversion for atrial fibrillation
- M.P. Van Den Berg T. Van Noord J. Brouwer J. Haaksma D.J. Van Veldhuisen H.J. Crijns I.C. Van Gelder Clustering of RR intervals predicts effective electrical cardioversion for atrial fibrillation J Cardiovasc Electrophysiol 15 2004 1027-1033
- (2004) J. Cardiovasc. Electrophysiol. , vol.15 , pp. 1027-1033
- Van Den Berg, M.P.¹ Van Noord, T.² Brouwer, J.³ Haaksma, J.⁴ Van Veldhuisen, D.J.⁵ Crijns, H.J.⁶ Van Gelder, I.C.⁷

31
- 0037014593
- Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation
- H. Oral B.P. Knight M. Ozaydin H. Tada A. Chugh S. Hassan C. Scharf S.W. Lai R. Greenstein F. Pelosi Jr S.A. Strickberger F. Morady Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation J Am Coll Cardiol 40 2002 100-104
- (2002) J. Am. Coll. Cardiol. , vol.40 , pp. 100-104
- Oral, H.¹ Knight, B.P.² Ozaydin, M.³ Tada, H.⁴ Chugh, A.⁵ Hassan, S.⁶ Scharf, C.⁷ Lai, S.W.⁸ Greenstein, R.⁹ Pelosi Jr., F.¹⁰ Strickberger, S.A.¹¹ Morady, F.¹²

32
- 1942502835
- The impact of atrial prevention and termination therapies on atrial tachyarrhythmia burden in patients receiving a dual-chamber defibrillator for ventricular arrhythmias
- P.A. Friedman J.H. Ip M. Jazayeri J.H. Lobban B. Olshansky D. Zhou T. Knowles D.E. Euler The impact of atrial prevention and termination therapies on atrial tachyarrhythmia burden in patients receiving a dual-chamber defibrillator for ventricular arrhythmias J Interv Card Electrophysiol 10 2004 103-110
- (2004) J. Interv. Card. Electrophysiol. , vol.10 , pp. 103-110
- Friedman, P.A.¹ Ip, J.H.² Jazayeri, M.³ Lobban, J.H.⁴ Olshansky, B.⁵ Zhou, D.⁶ Knowles, T.⁷ Euler, D.E.⁸

33
- 0028032062
- Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia
- R.L. Page W.E. Wilkinson W.K. Clair E.A. McCarthy E.L. Pritchett Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia Circulation 89 1994 224-227
- (1994) Circulation , vol.89 , pp. 224-227
- Page, R.L.¹ Wilkinson, W.E.² Clair, W.K.³ McCarthy, E.A.⁴ Pritchett, E.L.⁵

34
- 0001601485
- Measuring quality of life and symptom severity in patients with atrial fibrillation
- C. Maglio SJ M. Paquette P. Dorian A. Bygrave K. Wood G.M. Ayers Measuring quality of life and symptom severity in patients with atrial fibrillation Pacing Clin Electrophysiol 21 1998 839
- (1998) Pacing Clin. Electrophysiol. , vol.21 , pp. 839
- Maglio, C.¹ Paquette, M.² Dorian, P.³ Bygrave, A.⁴ Wood, K.⁵ Ayers, G.M.⁶

35
- 0037727953
- Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life
- D.M. Newman P. Dorian M. Paquette N. Sulke M.R. Gold D.S. Schwartzman K. Schaaf K. Wood L. Johnson Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life Am Heart J 145 2003 841-846
- (2003) Am. Heart J. , vol.145 , pp. 841-846
- Newman, D.M.¹ Dorian, P.² Paquette, M.³ Sulke, N.⁴ Gold, M.R.⁵ Schwartzman, D.S.⁶ Schaaf, K.⁷ Wood, K.⁸ Johnson, L.⁹

36
- 0036088496
- Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation
- P. Dorian M. Paquette D. Newman M. Green S.J. Connolly M. Talajic D. Roy Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation Am Heart J 143 2002 984-990
- (2002) Am. Heart J. , vol.143 , pp. 984-990
- Dorian, P.¹ Paquette, M.² Newman, D.³ Green, M.⁴ Connolly, S.J.⁵ Talajic, M.⁶ Roy, D.⁷

37
- 3042818130
- Quality of life as an endpoint for atrial fibrillation research: Pitfalls and practice
- D. Newman Quality of life as an endpoint for atrial fibrillation research: Pitfalls and practice Heart Rhythm 1 2004 20-26
- (2004) Heart Rhythm , vol.1 , pp. 20-26
- Newman, D.¹

38
- 0029834846
- Quality of life in patients with atrial fibrillation
- L.S. Jenkins R.S. Bubien Quality of life in patients with atrial fibrillation Cardiol Clin 14 1996 597-606
- (1996) Cardiol. Clin. , vol.14 , pp. 597-606
- Jenkins, L.S.¹ Bubien, R.S.²

39
- 0035940379
- ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences
- (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
- V. Fuster L.E. Ryden R.W. Asinger D.S. Cannom H.J. Crijns R.L. Frye J.L. Halperin G.N. Kay W.W. Klein S. Levy R.L. McNamara E.N. Prystowsky L.S. Wann D.G. Wyse R.J. Gibbons E.M. Antman J.S. Alpert D.P. Faxon G. Gregoratos L.F. Hiratzka A.K. Jacobs R.O. Russell S.C. Smith Jr A. Alonso-Garcia C. Blomstrom-Lundqvist G. de Backer M. Flather J. Hradec A. Oto A. Parkhomenko S. Silber A. Torbicki ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology Circulation 104 2001 2118-2150
- (2001) Circulation , vol.104 , pp. 2118-2150
- Fuster, V.¹ Ryden, L.E.² Asinger, R.W.³ Cannom, D.S.⁴ Crijns, H.J.⁵ Frye, R.L.⁶ Halperin, J.L.⁷ Kay, G.N.⁸ Klein, W.W.⁹ Levy, S.¹⁰ McNamara, R.L.¹¹ Prystowsky, E.N.¹² Wann, L.S.¹³ Wyse, D.G.¹⁴ Gibbons, R.J.¹⁵ Antman, E.M.¹⁶ Alpert, J.S.¹⁷ Faxon, D.P.¹⁸ Gregoratos, G.¹⁹ Hiratzka, L.F.²⁰ more..

40
- 0033820135
- The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy
- P. Dorian JW M. Paquette D. Newman K. Wood G.M. Ayers J. Camm M. Akhtar B. Luderitz The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy J Am Coll Cardiol 36 2000 1303-1309
- (2000) J. Am. Coll. Cardiol. , vol.36 , pp. 1303-1309
- Dorian, P.¹ Paquette, M.² Newman, D.³ Wood, K.⁴ Ayers, G.M.⁵ Camm, J.⁶ Akhtar, M.⁷ Luderitz, B.⁸

41
- 1342265962
- Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: Observations from the Canadian Trial of Atrial Fibrillation
- P. Dorian I. Mangat Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: Observations from the Canadian Trial of Atrial Fibrillation Card Electrophysiol Rev 7 2003 276-279
- (2003) Card. Electrophysiol. Rev. , vol.7 , pp. 276-279
- Dorian, P.¹ Mangat, I.²

42
- 0037022841
- Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation
- H. Oral B.P. Knight H. Tada M. Ozaydin A. Chugh S. Hassan C. Scharf S.W. Lai R. Greenstein F. Pelosi Jr S.A. Strickberger F. Morady Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation Circulation 105 2002 1077-1081
- (2002) Circulation , vol.105 , pp. 1077-1081
- Oral, H.¹ Knight, B.P.² Tada, H.³ Ozaydin, M.⁴ Chugh, A.⁵ Hassan, S.⁶ Scharf, C.⁷ Lai, S.W.⁸ Greenstein, R.⁹ Pelosi Jr., F.¹⁰ Strickberger, S.A.¹¹ Morady, F.¹²

43
- 0242694560
- Catheter ablation for paroxysmal atrial fibrillation: Segmental pulmonary vein ostial ablation versus left atrial ablation
- H. Oral C. Scharf A. Chugh B. Hall P. Cheung E. Good S. Veerareddy F. Pelosi Jr F. Morady Catheter ablation for paroxysmal atrial fibrillation: Segmental pulmonary vein ostial ablation versus left atrial ablation Circulation 108 2003 2355-2360
- (2003) Circulation , vol.108 , pp. 2355-2360
- Oral, H.¹ Scharf, C.² Chugh, A.³ Hall, B.⁴ Cheung, P.⁵ Good, E.⁶ Veerareddy, S.⁷ Pelosi Jr., F.⁸ Morady, F.⁹

44
- 17144431098
- Differential response to antiarrhythmic drug therapy in focal-triggered substrate mediated atrial fibrillation following failed ablation
- D. Darbar S. Asirvatham T.M. Munger S.C. Hammill D.L. Packer Differential response to antiarrhythmic drug therapy in focal-triggered substrate mediated atrial fibrillation following failed ablation Pacing Clin Electrophysiol 24 2001 657-658
- (2001) Pacing Clin. Electrophysiol. , vol.24 , pp. 657-658
- Darbar, D.¹ Asirvatham, S.² Munger, T.M.³ Hammill, S.C.⁴ Packer, D.L.⁵

45
- 16544370107
- ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards
- (Writing Committee to Develop Data Standards on Atrial Fibrillation)
- R.L. McNamara L.M. Brass J.P. Drozda Jr A.S. Go J.L. Halperin C.R. Kerr S. Levy D.J. Malenka S. Mittal F. Pelosi Jr Y. Rosenberg D. Stryer D.G. Wyse M.J. Radford D.C. Goff Jr F.L. Grover P.A. Heidenreich E.D. Peterson R.F. Redberg ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Data Standards on Atrial Fibrillation) Circulation 109 2004 3223-3243
- (2004) Circulation , vol.109 , pp. 3223-3243
- McNamara, R.L.¹ Brass, L.M.² Drozda, J.P.³ Go, A.S.⁴ Halperin, J.L.⁵ Kerr, C.R.⁶ Levy, S.⁷ Malenka, D.J.⁸ Mittal, S.⁹ Pelosi Jr., F.¹⁰ Rosenberg, Y.¹¹ Stryer, D.¹² Wyse, D.G.¹³ Radford, M.J.¹⁴ Goff Jr., D.C.¹⁵ Grover, F.L.¹⁶ Heidenreich, P.A.¹⁷ Peterson, E.D.¹⁸ Redberg, R.F.¹⁹

46
- 0037418332
- Asymptomatic or "silent" atrial fibrillation: Frequency in untreated patients and patients receiving azimilide
- R.L. Page T.W. Tilsch S.J. Connolly D.J. Schnell S.R. Marcello W.E. Wilkinson E.L. Pritchett Asymptomatic or "silent" atrial fibrillation: Frequency in untreated patients and patients receiving azimilide Circulation 107 2003 1141-1145
- (2003) Circulation , vol.107 , pp. 1141-1145
- Page, R.L.¹ Tilsch, T.W.² Connolly, S.J.³ Schnell, D.J.⁴ Marcello, S.R.⁵ Wilkinson, W.E.⁶ Pritchett, E.L.⁷

47
- 0035810143
- Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation
- C. Ozcan A. Jahangir P.A. Friedman P.J. Patel T.M. Munger R.F. Rea M.A. Lloyd D.L. Packer D.O. Hodge B.J. Gersh S.C. Hammill W.K. Shen Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation N Engl J Med 344 2001 1043-1051
- (2001) N. Engl. J. Med. , vol.344 , pp. 1043-1051
- Ozcan, C.¹ Jahangir, A.² Friedman, P.A.³ Patel, P.J.⁴ Munger, T.M.⁵ Rea, R.F.⁶ Lloyd, M.A.⁷ Packer, D.L.⁸ Hodge, D.O.⁹ Gersh, B.J.¹⁰ Hammill, S.C.¹¹ Shen, W.K.¹²

48
- 0034646389
- Clinical outcomes after ablation and pacing therapy for atrial fibrillation
- M.A. Wood C. Brown-Mahoney G.N. Kay K.A. Ellenbogen Clinical outcomes after ablation and pacing therapy for atrial fibrillation Circulation 101 2000 1138-1144
- (2000) Circulation , vol.101 , pp. 1138-1144
- Wood, M.A.¹ Brown-Mahoney, C.² Kay, G.N.³ Ellenbogen, K.A.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.